Tag: lymphoma

Latest articles

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GlaxoSmithKline (GSK) have reported positive interim Phase II clinical trial safety and immunogenicity data for Medicago’s plant-derived COVID-19 vaccine candidate, which has...
Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic

Challenges in recruiting during the pandemic

Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription